240 related articles for article (PubMed ID: 2958955)
21. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
Vila V; Regañón E; Aznar J; Navarro G; Salas M
Thromb Res; 1987 Mar; 45(5):437-49. PubMed ID: 2954261
[TBL] [Abstract][Full Text] [Related]
22. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
23. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
24. [Fibrinogen Bern I and fibrinogen Bern II: 2 hereditary fibrinogen variants with diverse biochemical properties].
Rupp C; Kuyas C; Haeberli A; Furlan M; von Fliedner V; Beck EA
Schweiz Med Wochenschr; 1981 Oct; 111(41):1543-5. PubMed ID: 7313627
[TBL] [Abstract][Full Text] [Related]
25. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
[TBL] [Abstract][Full Text] [Related]
26. [The effect of calcium 2+ ions on the decomposition of canine and human fibrin(ogen) by (human) plasmin].
Wolling H; Mischke R
Berl Munch Tierarztl Wochenschr; 1995 Oct; 108(10):373-9. PubMed ID: 7495409
[TBL] [Abstract][Full Text] [Related]
27. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, gamma 308K, gamma 308I, gamma 308A, and wild type (gamma 308N).
Okumura N; Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T
Electrophoresis; 2000 Jul; 21(12):2309-15. PubMed ID: 10939439
[TBL] [Abstract][Full Text] [Related]
28. The ability of fibrinogens, FI and FII, to support ADP-induced platelet aggregation.
Phillips HM; Mansouri A; Perry CA
Thromb Haemost; 1983 Aug; 50(2):527-9. PubMed ID: 6636032
[TBL] [Abstract][Full Text] [Related]
29. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
[TBL] [Abstract][Full Text] [Related]
31. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
Bini A; Itoh Y; Kudryk BJ; Nagase H
Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
[TBL] [Abstract][Full Text] [Related]
32. The polymerization pocket "a" within the carboxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site.
Côté HC; Pratt KP; Davie EW; Chung DW
J Biol Chem; 1997 Sep; 272(38):23792-8. PubMed ID: 9295325
[TBL] [Abstract][Full Text] [Related]
33. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of divalent cations in the plasmin degradation of fibrinogen.
Dang CV; Bell WR; Ebert RF; Starksen NF
Arch Biochem Biophys; 1985 May; 238(2):452-7. PubMed ID: 3158281
[TBL] [Abstract][Full Text] [Related]
35. Monocytic cell adhesion to intact and plasmin-modified fibrinogen: possible involvement of Mac-1 (CD11b/CD18) and ICAM-1 (CD54).
Arefieva TL; Krasnikova TL
J Cell Physiol; 2001 Sep; 188(3):403-9. PubMed ID: 11473367
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
[TBL] [Abstract][Full Text] [Related]
37. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
Bolliger-Stucki B; Lord ST; Furlan M
Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
[TBL] [Abstract][Full Text] [Related]
38. Degradation pathway of fibrinogen by plasmin.
Budzynski AZ; Marder VJ
Thromb Haemost; 1977 Dec; 38(4):793-800. PubMed ID: 146273
[TBL] [Abstract][Full Text] [Related]
39. The release of B beta 1-42 from fibrinogen and fibrin by plasmin.
Hurlet-Jensen A; Koehn JA; Nossel HL
Thromb Res; 1983 Mar; 29(6):609-17. PubMed ID: 6222508
[TBL] [Abstract][Full Text] [Related]
40. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation.
Lounes KC; Ping L; Gorkun OV; Lord ST
Biochemistry; 2002 Apr; 41(16):5291-9. PubMed ID: 11955079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
